Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer


ERTÜRK Z., BÜBER E. , Ozen H., ÇELİKBIÇAK Ö. , SALİH B. , Acan N. L.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, vol.16, no.3, pp.70-76, 2017 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.4274/uob.905
  • Title of Journal : UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Page Numbers: pp.70-76

Abstract

Objective: Immunotherapy with intravesical Bacillus Calmette-Guerin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects. We aimed to develop less toxic and more powerful therapeutic agents for the treatment of bladder cancer than live strain.